Wall Street Zen downgraded shares of Aurora Cannabis (NASDAQ:ACB - Free Report) from a hold rating to a sell rating in a research report released on Friday.
Aurora Cannabis Stock Performance
ACB traded up $0.22 during trading on Friday, reaching $4.92. 1,275,156 shares of the company were exchanged, compared to its average volume of 1,539,258. Aurora Cannabis has a 52 week low of $3.42 and a 52 week high of $7.20. The stock has a market cap of $276.45 million, a P/E ratio of 44.68 and a beta of 1.75. The firm has a 50 day moving average of $4.99 and a 200 day moving average of $4.76. The company has a current ratio of 4.31, a quick ratio of 2.16 and a debt-to-equity ratio of 0.13.
Aurora Cannabis (NASDAQ:ACB - Get Free Report) last released its quarterly earnings results on Wednesday, June 18th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by ($0.04). Aurora Cannabis had a net margin of 1.32% and a return on equity of 0.13%. The company had revenue of $63.34 million during the quarter, compared to analyst estimates of $88.85 million. On average, sell-side analysts forecast that Aurora Cannabis will post 0.46 EPS for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the stock. Goldman Sachs Group Inc. grew its holdings in shares of Aurora Cannabis by 4.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 743,903 shares of the company's stock worth $3,266,000 after purchasing an additional 29,099 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of Aurora Cannabis by 8.6% during the 4th quarter. Renaissance Technologies LLC now owns 714,655 shares of the company's stock worth $3,037,000 after buying an additional 56,400 shares during the period. Cubist Systematic Strategies LLC lifted its position in shares of Aurora Cannabis by 358.6% during the 1st quarter. Cubist Systematic Strategies LLC now owns 238,460 shares of the company's stock worth $1,047,000 after buying an additional 186,462 shares during the period. Northwest & Ethical Investments L.P. bought a new position in Aurora Cannabis in the 1st quarter valued at $452,000. Finally, Dimensional Fund Advisors LP raised its position in Aurora Cannabis by 7.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 84,921 shares of the company's stock valued at $361,000 after purchasing an additional 5,800 shares during the last quarter. Institutional investors and hedge funds own 47.63% of the company's stock.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access